Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer

NCT01264328 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Panitumumab + paclitaxel

Sponsor

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Collaborators

[object Object]
[object Object]